Stem Cell Transplantation

Light-chain (AL) amyloidosis is a systemic syndrome characterized by progressive organ dysfunction leading to organ failure and death. The heart is the most…

Background/Aims: The present Bayesian network meta-analysis (NMA) was to compare the efficacy of different chemotherapies and autologous stem cell transplantation (…

Rationale: Immunoglobulin light chain amyloidosis (AL amyloidosis) is characterized by the deposition of abnormal amyloid protein produced by a pathological plasma…

Systemic light-chain (AL) amyloidosis is an infiltrative disorder associated with an underlying plasma cells dyscrasia, in which monoclonal immunoglobulin light…

Amyloidosis is a rare disease caused by extracellular deposition of proteins in an insoluble beta-pleated physical conformation. Multiple causative proteins have…

In immunoglobulin light chain (AL) amyloidosis, amyloid fibril deposits, derived from immunoglobulin light chains produced by a clonal plasma cell dyscrasia,…

Immunoglobulin light chain amyloidosis is the most common type of systemic amyloidosis. Hematopoietic stem cell transplantation (HCT) is an effective treatment…

Dr. Surbhi Sidana is an Assistant professor of medicine in the division of blood & marrow transplantation at the Stanford University Medical Center. She…

Dr. Surbhi Sidana is an Assistant professor of medicine in the division of blood & marrow transplantation at the Stanford University Medical Center. She…

Maurizio Zangari is a Professor of Medicine at Myeloma Center of University of Arkansas for Medical Sciencesexternal link, opens in a new tab. Dr. Zangari trained…